POST Online Media Lite Edition



 

Endo settles New Yor opioid case

Christian Fernsby |
Endo announced that it and its subsidiaries, Endo Health Solutions, Endo Pharmaceutical, Par Pharmaceutica and Par Pharmaceutical Companies have settled three consolidated cases pending in Suffolk County Supreme Court in the State of New York: County of Suffolk v. Purdue Pharma, County of Nassau v. Purdue Pharma, and The State of New York v. Purdue Pharma.

Article continues below




The plaintiffs in the foregoing cases asserted various claims relating to the defendants' marketing and sale of prescription opioid medications and/or alleged failures to take adequate steps to identify and report suspicious orders. A jury trial on liability has been ongoing since June 2021.

As a result of the settlement, Endo's subsidiaries have been severed from the trial. The settlement fully and finally resolves all of the asserted claims in exchange for a total payment of $50 million. The settlement includes no admission of wrongdoing, fault or liability of any kind by Endo or its subsidiaries, and the settlement value should not be extrapolated to any other opioid-related cases or claims.


What to read next

Endo to pay $10 million after settlement in opioid cases
Founder of Insys Therapeutics arrested and charged with racketeering
Indivior sentenced to pay $289m in criminal penalties for unlawful marketing of opioid drug